HFS
HZNP

Hantz Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Hantz Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,483
Closed -$287K – 1259
2023
Q3 		$287K Buy
2,483
+717
+41% +$77K 0.01% 528
2023
Q2 		$182K Sell
1,766
-2,238
-56% -$236K ﹤0.01% 543
2023
Q1 		$437K Sell
4,004
-145,111
-97% -$16M 0.01% 481
2022
Q4 		$17M Buy
149,115
+1,712
+1% +$142K 0.51% 50
2022
Q3 		$9.12M Sell
147,403
-4,758
-3% -$332K 0.32% 95
2022
Q2 		$12.1M Buy
152,161
+2,083
+1% +$197K 0.41% 65
2022
Q1 		$15.8M Buy
150,078
+11,403
+8% +$1.11M 0.47% 50
2021
Q4 		$14.9M Buy
138,675
+10,045
+8% +$1.1M 0.43% 63
2021
Q3 		$14.1M Buy
128,630
+19,103
+17% +$1.98M 0.46% 57
2021
Q2 		$10.3M Buy
109,527
+7,434
+7% +$684K 0.38% 72
2021
Q1 		$9.4M Buy
102,093
+6,815
+7% +$575K 0.39% 67
2020
Q4 		$6.97M Buy
95,278
+2,779
+3% +$207K 0.31% 90
2020
Q3 		$7.18M Buy
92,499
+1,774
+2% +$122K 0.37% 71
2020
Q2 		$5.04M Buy
+90,725
New +$3.88M 0.28% 106

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hantz Financial Services's HZNP Position: Q4 2023 in Review

Hantz Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,483 shares — an estimated $287K sold.

Hantz Financial Services first reported a position in HZNP in Q2 2020 and held it in 14 quarters. The position peaked at $17M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Hantz Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Hantz Financial Services sold 2,483 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $287K.
  • Hantz Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 14 quarters.
  • Hantz Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $17M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Hantz Financial Services's 13F filing for Q4 2023, filed 14 Feb 2024.